Horng‐Heng Juang
Papers
2
Total Citations
21
H-Index
2
About
Horng-Heng Juang is a leading urological surgeon and researcher whose work centers on advancing surgical treatments for benign prostatic obstruction (BPO) and high-risk prostate cancer. His major contributions lie in comparing the efficacy and safety of modern minimally invasive techniques. Notably, his 2021 study comparing endoscopic enucleation of the prostate (ThuLEP and B-TUEP) with robotic-assisted simple prostatectomy (RASP) for prostates larger than 80 cm³ has garnered 16 citations, providing crucial evidence for surgical decision-making in aging males with large prostates. Juang also investigated neoadjuvant hormone therapy (NHT) prior to robotic-assisted radical prostatectomy, demonstrating its potential to improve outcomes in high-risk prostate cancer patients. This work, cited 5 times, addresses the critical challenge of reducing positive surgical margins and biochemical failure. Through these studies, Juang has helped clarify the roles of emerging technologies—from endoscopic enucleation to robotic surgery—in optimizing patient outcomes, making him a respected voice in the evolution of urological oncology and benign prostatic hyperplasia management.
Research Focus
Key Achievements
Top Papers
- 1
- 2